Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / Aug / Continuous Immunoglobulin E Ranges Set for Children
Oncology Digital and computational pathology Research and Innovations

Continuous Immunoglobulin E Ranges Set for Children

Study establishes age-specific reference intervals for healthy and allergic children

By Kathryn Wighton 08/28/2025 News 1 min read

Share

Children with allergic conditions had upper percentile immunoglobulin E levels more than 30 times higher than those without allergies, according to a recent study.

A prospective cross-sectional study, published in Pathology, was conducted to establish continuous age-related reference intervals (RIs) for total serum immunoglobulin E (IgE) in healthy term neonates and children, with and without allergic conditions. IgE is an antibody involved in allergic sensitization and immune defense against helminths, with concentrations that vary by age and are typically higher in patients with allergic disease. Previous studies have provided partitioned RIs, which may not reflect gradual age-related changes.

This investigation, part of the Harmonising Age Pathology Parameters in Kids project, included 441 participants from Melbourne, Australia, recruited between 2015 and 2016. Twelve neonates (≤72 hours old) and 429 children aged 30 days to 18 years were included, with 51.5 percent male representation. Of these, 305 participants had no reported allergic conditions, and 136 reported at least one allergic diagnosis (asthma, eczema, hay fever, or food allergy). Venous blood samples were collected during minor surgical procedures or routine neonatal care, processed under standardized laboratory protocols, and analyzed using a fluoroenzyme immunoassay.

Fractional polynomial regression and quantile regression were used to generate continuous RIs for the 2.5th and 97.5th percentiles, stratified by allergy status. In the non-allergic cohort, the 2.5th percentile RI was 2.00 IU/mL, and the 97.5th percentile was calculated as 37.29 + 101.95 × (age/10). In the allergic cohort, the corresponding equations were 1.50 + 0.30 × (age/10) for the lower bound and 1751.73 + 14.82 × (age/10) for the upper bound. IgE concentrations increased with age in both cohorts. The upper percentile values in the allergic group were more than 30 times higher than those in the non-allergic group, with smaller age-related variation observed in the allergic group.

This study reported continuous, equation-based pediatric IgE RIs using the fluoroenzyme immunoassay method in an ethnically diverse Australasian cohort. Separate RIs for allergic and non-allergic groups were provided. The non-allergic RIs may be applicable to other laboratories using the same analytical platform, but local verification is recommended due to possible demographic and environmental differences. The methodology described can be adapted by laboratories to establish population-specific continuous RIs.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Research and Innovations
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Research Roundup
Research and Innovations
Research Roundup

January 31, 2024

1 min read

From spatial transcriptomics to AI diagnosis, we bring you the latest news in pathology and laboratory medicine

Flexible Solutions With FlexVUE
Research and Innovations
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

Defining the Next Generation of NGS
Research and Innovations
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.